Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen

Journal of Immunology

Volumn 184, Issue 8, 2010, Pages 4143-4158

  Duong, Bao Hoa ^a   Ota, Takayuki ^a   Aït Azzouzene, Djemel ^a,b   Aoki Ota, Miyo ^a   Vela, José Luis ^a,c   Huber, Christoph ^a   Walsh, Kevin ^a   Gavin, Amanda L ^a   Nemazee, David ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BIOGEN   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CD23 ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PROTEIN BCL 2; AUTOANTIGEN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SUPERANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CLONAL ANERGY; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL DIFFERENTIATION; CELL LINEAGE; CYTOLOGY; GENETICS; HUMAN; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; PRE B LYMPHOCYTE; TRANSGENE; TRANSPLANTATION;

ANIMALS; AUTOANTIGENS; B-LYMPHOCYTE SUBSETS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN D; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRECURSOR CELLS, B-LYMPHOID; SINGLE-CHAIN ANTIBODIES; SPLEEN; SUPERANTIGENS; TRANSGENES;

EID: 77952763215     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903564     Document Type: Article

References (120)

1. Rowe, D. S., K. Hug, L. Forni, and B. Pernis. 1973. Immunoglobulin D as a lymphocyte receptor. J. Exp. Med. 138: 965-972.
2. Abney, E. R., and R. M. Parkhouse. 1974. Candidate for immunoglobulin D present on murine B lymphocytes. Nature 252: 600-602.
3. Melcher, U., E. S. Vitetta, M. McWilliams, M. E. Lamm, J. M. Phillips-Quagliata, and J. W. Uhr. 1974. Cell surface immunoglobulin. X. Identification of an IgD-like molecule on the surface of murine splenocytes. J. Exp. Med. 140: 1427-1431.
4. Vitetta, E. S., and J.W. Uhr. 1975. Immunoglobulin-receptors revisited. Science 189: 964-969.
5. Martin, L. N., and G. A. Leslie. 1977. Lymphocyte surface IgD and IgM in Macaca monkeys: ontogeny, tissue distribution and occurrence on individual lymphocytes. Immunology 33: 865-872.
6. Ruddick, J. H., and G. A. Leslie. 1977. Structure and biologic functions of human IgD. XI. Identification and ontogeny of a rat lymphocyte immunoglobulin having antigenic cross-reactivity with human IgD. J. Immunol. 118: 1025-1031.
7. Geisberger, R., M. Lamers, and G. Achatz. 2006. The riddle of the dual expression of IgM and IgD. Immunology 118: 429-437. (Pubitemid 44079563)
8. Maki, R., W. Roeder, A. Traunecker, C. Sidman, M. Wabl, W. Raschke, and S. Tonegawa. 1981. The role of DNA rearrangement and alternative RNA processing in the expression of immunoglobulin delta genes. Cell 24: 353-365. (Pubitemid 11066819)
9. Cheng, H. L., F. R. Blattner, L. Fitzmaurice, J. F. Mushinski, and P. W. Tucker. 1982. Structure of genes for membrane and secreted murine IgD heavy chains. Nature 296: 410-415.
10. Vitetta, E. S., and J.W. Uhr. 1977. IgD and B cell differentiation. Immunol. Rev. 37: 50-88.
11. Wilson, M., E. Bengtén, N. W. Miller, L. W. Clem, L. Du Pasquier, and G. W. Warr. 1997. A novel chimeric Ig heavy chain from a teleost fish shares similarities to IgD. Proc. Natl. Acad. Sci. U.S.A. 94: 4593-4597.
12. Zhao, Y., I. Kacskovics, Q. Pan, D. A. Liberles, J. Geli, S. K. Davis, H. Rabbani, and L. Hammarstrom. 2002. Artiodactyl IgD: the missing link. J. Immunol. 169: 4408-4416.
13. Zhao, Y., Q. Pan-Hammarström, I. Kacskovics, and L. Hammarström. 2003. The porcine Ig delta gene: unique chimeric splicing of the first constant region domain in its heavy chain transcripts. J. Immunol. 171: 1312-1318. (Pubitemid 36900062)
14. Ohta, Y., and M. Flajnik. 2006. IgD, like IgM, is a primordial immunoglobulin class perpetuated in most jawed vertebrates. Proc. Natl. Acad. Sci. U.S.A. 103: 10723-10728.
15. Zhao, Y., H. Rabbani, A. Shimizu, and L. Hammarström. 2000. Mapping of the chicken immunoglobulin heavy-chain constant region gene locus reveals an inverted alpha gene upstream of a condensed upsilon gene. Immunology 101: 348-353.
16. Lundqvist, M. L., D. L. Middleton, S. Hazard, and G. W. Warr. 2001. The immunoglobulin heavy chain locus of the duck. Genomic organization and expression of D, J, and C region genes. J. Biol. Chem. 276: 46729-46736.
17. Lanning, D. K., S. K. Zhai, and K. L. Knight. 2003. Analysis of the 39 Cmu region of the rabbit Ig heavy chain locus. Gene 309: 135-144.
18. Fu, S. M., R. J. Winchester, and H. G. Kunkel. 1975. Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes. J. Immunol. 114: 250-252.
19. Salsano, F., S. S. Froland, J. B. Natvig, and T. E. Michaelsen. 1974. Same idiotype of B-lymphocyte membrane IgD and IgM. Formal evidence for monoclonality of chronic lymphocytic leukemia cells. Scand. J. Immunol. 3: 841-846.
20. Pernis, B., J. C. Brouet, and M. Seligmann. 1974. IgD and IgM on the membrane of lymphoid cells in macroglobulinemia. Evidence for identity of membrane IgD and IgM antibody activity in a case with anti-IgG receptors. Eur. J. Immunol. 4: 776-778.
21. Goding, J. W., and J. E. Layton. 1976. Antigen-induced co-capping of IgM and IgD-like receptors on murine B cells. J. Exp. Med. 144: 852-857.
22. Yuan, D., P. L. Witte, J. Tan, J. Hawley, and T. Dang. 1996. Regulation of IgM and IgD heavy chain gene expression: effect of abrogation of intergenic transcriptional termination. J. Immunol. 157: 2073-2081. (Pubitemid 126449683)
23. Reed, D. J., J. Hawley, T. Dang, and D. Yuan. 1994. Role of differential mRNA stability in the regulated expression of IgM and IgD. J. Immunol. 152: 5330-5336.
24. Havran, W. L., D. L. DiGiusto, and J. C. Cambier. 1984. mIgM:mIgD ratios on B cells: mean mIgD expression exceeds mIgM by 10-fold on most splenic B cells. J. Immunol. 132: 1712-1716.
25. Hayakawa, K., R. R. Hardy, M. Honda, L. A. Herzenberg, A. D. Steinberg, and L. A. Herzenberg. 1984. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl. Acad. Sci. U.S.A. 81: 2494-2498.
26. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2: 323-335.
27. Allman, D. M., S. E. Ferguson, and M. P. Cancro. 1992. Peripheral B cell maturation. I. Immature peripheral B cells in adults are heat-stable antigenhi and exhibit unique signaling characteristics. J. Immunol. 149: 2533-2540.
28. Allman, D. M., S. E. Ferguson, V. M. Lentz, and M. P. Cancro. 1993. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 151: 4431-4444.
29. Rolink, A. G., J. Andersson, and F. Melchers. 1998. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur. J. Immunol. 28: 3738-3748.
30. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190: 75-89.
31. Allman, D., R. C. Lindsley, W. DeMuth, K. Rudd, S. A. Shinton, and R. R. Hardy. 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167: 6834-6840. (Pubitemid 33144175)
32. Lutz, C., B. Ledermann, M. H. Kosco-Vilbois, A. F. Ochsenbein, R. M. Zinkernagel, G. Köhler, and F. Brombacher. 1998. IgD can largely substitute for loss of IgM function in B cells. Nature 393: 797-801. (Pubitemid 28299492)
33. Brink, R., C. C. Goodnow, J. Crosbie, E. Adams, J. Eris, D. Y. Mason, S. B. Hartley, and A. Basten. 1992. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J. Exp. Med. 176: 991-1005.
34. Vitetta, E. S., U. Melcher, M. McWilliams, M. E. Lamm, J. M. Phillips-Quagliata, and J. W. Uhr. 1975. Cell surface immunoglobulin. XI. The appearance of an IgD-like molecule on murine lymphoid cells during ontogeny. J. Exp. Med. 141: 206-215.
35. Klinman, N. R. 1996. The "clonal selection hypothesis" and current concepts of B cell tolerance. Immunity 5: 189-195.
36. Nossal, G. J. 1983. Cellular mechanisms of immunologic tolerance. Annu. Rev. Immunol. 1: 33-62.
37. Cambier, J. C., J. R. Kettman, E. S. Vitetta, and J. W. Uhr. 1976. Differential susceptibility of neonatal and adult murine spleen cells to in vitro induction of B-cell tolerance. J. Exp. Med. 144: 293-297.
38. Carsetti, R., G. Köhler, and M. C. Lamers. 1993. A role for immunoglobulin D: interference with tolerance induction. Eur. J. Immunol. 23: 168-178.
39. Finkelman, F. D., J. M. Holmes, O. I. Dukhanina, and S. C. Morris. 1995. Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J. Exp. Med. 181: 515-525.
40. Goodnow, C. C., J. Crosbie, H. Jorgensen, R. A. Brink, and A. Basten. 1989. Induction of self-tolerance in mature peripheral B lymphocytes. [see comments] Nature 342: 385-391.
41. Parry, S. L., J. Hasbold, M. Holman, and G. G. Klaus. 1994. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J. Immunol. 152: 2821-2829.
42. Russell, D. M., Z. Dembić, G. Morahan, J. F. Miller, K. Bürki, and D. Nemazee. 1991. Peripheral deletion of self-reactive B cells. Nature 354: 308-311.
43. Cyster, J. G., S. B. Hartley, and C. C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. [see comments] Nature 371: 389-395.
44. Fulcher, D. A., and A. Basten. 1994. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J. Exp. Med. 179: 125-134.
45. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S.Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
46. Hertz, M., and D. Nemazee. 1997. BCR ligation induces receptor editing in IgM+IgD- bone marrow B cells in vitro. Immunity 6: 429-436.
47. Tiegs, S. L., D. M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177: 1009-1020.
48. Sandel, P. C., and J. G. Monroe. 1999. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity 10: 289-299.
49. Nemazee, D., and M. Weigert. 2000. Revising B cell receptors. J. Exp. Med. 191: 1813-1817.
50. Venkitaraman, A. R., G. T. Williams, P. Dariavach, and M. S. Neuberger. 1991. The B-cell antigen receptor of the five immunoglobulin classes. Nature 352: 777-781.
51. Campbell, K. S., E. J. Hager, and J. C. Cambier. 1991. Alpha-chains of IgM and IgD antigen receptor complexes are differentially N-glycosylated MB-1-related molecules. J. Immunol. 147: 1575-1580.
52. Wienands, J., and M. Reth. 1991. The B cell antigen receptor of class IgD can be expressed on the cell surface in two different forms. Eur. J. Immunol. 21: 2373-2378.
53. Kim, K. M., and M. Reth. 1995. The B cell antigen receptor of class IgD induces a stronger and more prolonged protein tyrosine phosphorylation than that of class IgM. J. Exp. Med. 181: 1005-1014.
54. Monroe, J. G., W. L. Havran, and J. C. Cambier. 1983. B lymphocyte activation: entry into cell cycle is accompanied by decreased expression of IgD but not IgM. Eur. J. Immunol. 13: 208-213.
55. Bourgois, A., K. Kitajima, I. R. Hunter, and B. A. Askonas. 1977. Surface immunoglobulins of lipopolysaccharide-stimulated spleen cells. The behavior of IgM, IgD and IgG. Eur. J. Immunol. 7: 151-153.
56. Hodgkin, P. D., J.-H. Lee, and A. B. Lyons. 1996.B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184: 277-281.
57. Haas, D., and G. F. Hoffmann. 2006. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J. Rare Dis. 1: 13.
58. Kluin, P. M., H. Kayano, V. J. Zani, H. C. Kluin-Nelemans, P. W. Tucker, E. Satterwhite, andM. J. Dyer. 1995. IgD class switching: identification of a novel recombination site in neoplastic and normalBcells. Eur. J. Immunol. 25: 3504-3508.
59. Koelsch, K., N. Y. Zheng, Q. Zhang, A. Duty, C. Helms, M. D. Mathias, M. Jared, K. Smith, J. D. Capra, and P. C. Wilson. 2007. Mature B cells class switched to IgD are autoreactive in healthy individuals. J. Clin. Invest. 117: 1558-1565.
60. Chen, K., W. Xu, M. Wilson, B. He, N. W. Miller, E. Bengtén, E. S. Edholm, P. A. Santini, P. Rath, A. Chiu, et al. 2009. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cellstimulating programs in basophils. Nat. Immunol. 10: 889-898.
61. Roes, J., and K. Rajewsky. 1993. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J. Exp. Med. 177: 45-55.
62. Nitschke, L.,M. H. Kosco, G. Köhler, and M. C. Lamers. 1993. Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc. Natl. Acad. Sci. U.S.A. 90: 1887-1891.
63. Aït-Azzouzene, D., L. Verkoczy, J. Peters, A. Gavin, P. Skog, J. L. Vela, and D. Nemazee. 2005. An immunoglobulin C kappa-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system. J. Exp. Med. 201: 817-828.
64. Ait-Azzouzene, D., A. L. Gavin, P. Skog, B. Duong, and D. Nemazee. 2006. Effect of cell:cell competition and BAFF expression on peripheral B cell tolerance and B-1 cell survival in transgenic mice expressing a low level of Ig-kappa-reactive macroself antigen. Eur. J. Immunol. 36: 985-996.
65. Aït-Azzouzene, D., L. Verkoczy, B. Duong, P. Skog, A. L. Gavin, and D. Nemazee. 2006. Split tolerance in peripheral B cell subsets in mice expressing a low level of Igkappa-reactive ligand. J. Immunol. 176: 939-948. (Pubitemid 43099692)
66. Gavin, A. L., B. Duong, P. Skog, D. Aït-Azzouzene, D. R. Greaves, M. L. Scott, and D. Nemazee. 2005. deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models. J. Immunol. 175: 319-328.
67. Strasser, A., S. Whittingham, D. L. Vaux, M. L. Bath, J. M. Adams, S. Cory, and A. W. Harris. 1991. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 88: 8661-8665.
68. Stall, A. M., and M. R. Loken. 1984. Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies. J. Immunol. 132: 787-795. (Pubitemid 14183678)
69. Lindsley, R. C., M. Thomas, B. Srivastava, and D. Allman. 2007. Generation of peripheral B cells occurs via two spatially and temporally distinct pathways. Blood 109: 2521-2528.
70. Cariappa, A., C. Chase, H. Liu, P. Russell, and S. Pillai. 2007. Naive recirculating B cells mature simultaneously in the spleen and bone marrow. Blood 109: 2339-2345. (Pubitemid 46425873)
71. Merrell, K. T., R. J. Benschop, S. B. Gauld, K. Aviszus, D. Decote-Ricardo, L. J. Wysocki, and J. C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity 25: 953-962.
72. Seo, S. J., L. Mandik-Nayak, and J. Erikson. 2003. B cell anergy and systemic lupus erythematosus. Curr. Dir. Autoimmun. 6: 1-20.
73. Schiemann, B., J. L. Gommerman, K. Vora, T. G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M. L. Scott. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293: 2111-2114. (Pubitemid 32848063)
74. Schneider, P., H. Takatsuka, A. Wilson, F. Mackay, A. Tardivel, S. Lens, T. G. Cachero, D. Finke, F. Beermann, and J. Tschopp. 2001. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 194: 1691-1697.
75. Noorchashm, H., A. Bui, H. L. Li, A. Eaton, L. Mandik-Nayak, C. Sokol, K. M. Potts, E. Puré, and J. Erikson. 1999. Characterization of anergic anti- DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int. Immunol. 11: 765-776.
76. Nemazee, D. 2006. Receptor editing in lymphocyte development and central tolerance. Nat. Rev. Immunol. 6: 728-740.
77. Chevrier, S., C. Genton, A. Kallies, A. Karnowski, L. A. Otten, B. Malissen, M. Malissen, M. Botto, L. M. Corcoran, S. L. Nutt, and H. Acha-Orbea. 2009. CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche. Proc. Natl. Acad. Sci. U.S.A. 106: 3895-3900.
78. Lesley, R., Y. Xu, S. L. Kalled, D. M. Hess, S. R. Schwab, H. B. Shu, and J. G. Cyster. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20: 441-453. (Pubitemid 38482122)
79. Thien, M., T. G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20: 785-798. (Pubitemid 38757447)
80. Lang, J., B. Arnold, G. Hammerling, A. W. Harris, S. Korsmeyer, D. Russell, A. Strasser, and D. Nemazee. 1997. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J. Exp. Med. 186: 1513-1522.
81. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173: 1213-1225.
82. Kincade, P. W., A. R. Lawton, D. E. Bockman, and M. D. Cooper. 1970. Suppression of immunoglobulin G synthesis as a result of antibody-mediated suppression of immunoglobulin M synthesis in chickens. Proc. Natl. Acad. Sci. U.S.A. 67: 1918-1925.
83. Leslie, G. A., and L. N. Martin. 1973. Suppression of chicken immunoglobulin ontogeny by F(ab9)2 fragments of anti-mu chain and by anti-L chain. Int. Arch. Allergy Appl. Immunol. 45: 429-438.
84. Lawton, A. R., 3rd, R. Asofsky, M. B. Hylton, and M. D. Cooper. 1972. Suppression of immunoglobulin class synthesis in mice. I. Effects of treatment with antibody to -chain. J. Exp. Med. 135: 277-297.
85. Manning, D. D., and J. W. Jutila. 1972. Immunosuppression in mice injected with heterologous anti-immunoglobulin antisera. J. Immunol. 108: 282-285.
86. Manning, D. D., and J. W. Jutila. 1972. Immunosuppression of mice injected with heterologous anti-immunoglobulin heavy chain antisera. J. Exp. Med. 135: 1316-1333.
87. Murgita, R. A., C. A. Mattioli, and T. B. Tomasi, Jr. 1973. Production of a runting syndrome and selective A deficiency in mice by the administration of anti-heavy chain antisera. J. Exp. Med. 138: 209-228.
88. Cooper, M. D., J. F. Kearney, W. E. Gathings, and A. R. Lawton. 1980. Effects of anti-Ig antibodies on the development and differentiation of B cells. Immunol. Rev. 52: 29-53.
89. Gordon, J., R. A. Murgita, and T. B. Tomasi, Jr. 1975. The immune response of mice treated with anti-mu antibodies: the effect on antibody-forming cells, their precursors and helper cells assayed in vitro. J. Immunol. 114: 1808-1812.
90. Raff, M. C., M. Megson, J. J. Owen, and M. D. Cooper. 1976. Early production of intracellular IgM by B-lymphocyte precursors in mouse. Nature 259: 224-226.
91. Layton, J. E., G. R. Johnson, D. W. Scott, and G. J. Nossal. 1978. The anti-delta suppressed mouse. Eur. J. Immunol. 8: 325-330.
92. Parkhouse, R. M., and D. W. Dresser. 1978. Effect of anti-IgD serum on immune responses. Adv. Exp. Med. Biol. 107: 43-51.
93. Jacobson, E. B., Y. Baine, Y. W. Chen, T. Flotte, M. J. O'Neil, B. Pernis, G. W. Siskind, G. J. Thorbecke, and P. Tonda. 1981. Physiology of IgD. I. Compensatory phenomena in B lymphocyte activation in mice treated with anti-IgD antibodies. J. Exp. Med. 154: 318-332.
94. Tokuhisa, T., F. T. Gadus, L. A. Herzenberg, and L. A. Herzenberg. 1981. Monoclonal antibody to an IgD allotype induces a new type of allotype suppression in the mouse. J. Exp. Med. 154: 921-934.
95. Thorbecke, G. J., Y. Baine, B. Xue, Y. W. Chen, B. Pernis, G. W. Siskind, and E. B. Jacobson. 1982. Effects of allotype specific anti-IgD on the immune responses of homozygous mice. Ann. N. Y. Acad. Sci. 399: 304-309.
96. Metcalf, E. S., J. J. Mond, I. Scher, M. A. LaVeck, and F. D. Finkelman. 1982. B-cell function in mice treated with anti-IgD from birth. Ann. N. Y. Acad. Sci. 399: 351-359.
97. Baine, Y., Y. W. Chen, E. B. Jacobson, B. Pernis, G. W. Siskind, and G. J. Thorbecke. 1982. Chronic suppression in mice with anti-IgD: role of Bcell numbers. Ann. N. Y. Acad. Sci. 399: 360-367.
98. Baine, Y., Y. W. Chen, E. B. Jacobson, B. Pernis, G. W. Siskind, and G. J. Thorbecke. 1982. Physiology of Igd. II. Lack of humoral immune responsiveness in lymph nodes of mice treated with anti-IgD from birth. Eur. J. Immunol. 12: 882-886.
99. Skelly, R. R., Y. Baine, A. Ahmed, B. Xue, and G. J. Thorbecke. 1983. Cell surface phenotype of lymphoid cells from normal mice and mice treated with monoclonal anti-IgD from birth. J. Immunol. 130: 15-18.
100. Dresser, D. W., R. M. Parkhouse, and A. M. Popham. 1983. Pretreatment of mice with anti-IgD serum does not result in suppression of immune responsiveness induced by TNP-AECM-Ficoll or lipopolysaccharide. Immunology 48: 497-501.
101. Xue, B., T. Hirano, B. Pernis, Z. Ovary, and G. J. Thorbecke. 1984. Physiology of IgD. III. Effect of treatment with anti-IgD from birth on the magnitude and isotype distribution of the immune response in the spleen. Eur. J. Immunol. 14: 81-86.
102. Denis, O., F. Macedo-Soares, D. Latinne, F. Nisol, and H. Bazin. 1994. In vivo study of mIgM and mIgD cross-linking on murine B cells. Scand. J. Immunol. 39: 625-632.
103. Finkelman, F. D., J. J. Mond, and E. S. Metcalf. 1983. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgDB lymphocyte population. J. Immunol. 131: 593-600.
104. Metcalf, E. S., J. J. Mond, and F. D. Finkelman. 1983. Effects of neonatal anti-delta antibody treatment on the murine immune system. II. Functional capacity of a stable sIgM+sIa+sIgD- B cell population. J. Immunol. 131: 601-605.
105. Melamed, D., R. J. Benschop, J. C. Cambier, and D. Nemazee. 1998. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 92: 173-182. (Pubitemid 28073041)
106. Meyer-Bahlburg, A., S. F. Andrews, K. O. Yu, S. A. Porcelli, and D. J. Rawlings. 2008. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J. Exp. Med. 205: 155-168.
107. Hsu, B. L., S. M. Harless, R. C. Lindsley, D. M. Hilbert, and M. P. Cancro. 2002. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J. Immunol. 168: 5993-5996.
108. Kiefer, K., P. B. Nakajima, J. Oshinsky, S. H. Seeholzer, M. Radic, G. C. Bosma, and M. J. Bosma. 2008. Antigen receptor editing in anti-DNA transitional B cells deficient for surface IgM. J. Immunol. 180: 6094-6106.
109. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, D. Y. Mason, H. Jorgensen, R. A. Brink, H. Pritchard-Briscoe, M. Loughnan, et al. 1989. Clonal silencing of self-reactive B lymphocytes in a transgenic mouse model. Cold Spring Harb. Symp. Quant. Biol. 54: 907-920.
110. Thompson, J. S., S. A. Bixler, F. Qian, K. Vora, M. L. Scott, T. G. Cachero, C. Hession, P. Schneider, I. D. Sizing, C. Mullen, et al. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293: 2108-2111.
111. Sandel, P. C., M. Gendelman, G. Kelsoe, and J. G. Monroe. 2001. Definition of a novel cellular constituent of the bone marrow that regulates the response of immature B cells to B cell antigen receptor engagement. J. Immunol. 166: 5935-5944.
112. Tze, L. E., K. L. Hippen, and T. W. Behrens. 2003. Late immature B cells (IgMhighIgDneg) undergo a light chain receptor editing response to soluble self-antigen. J. Immunol. 171: 678-682.
113. Dingjan, G. M., S. Middendorp, K. Dahlenborg, A. Maas, F. Grosveld, and R. W. Hendriks. 2001. Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse. J. Exp. Med. 193: 1169-1178.
114. Hayakawa, K., R. R. Hardy, and L. A. Herzenberg. 1986. Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur. J. Immunol. 16: 450-456.
115. Carey, J. B., C. S. Moffatt-Blue, L. C. Watson, A. L. Gavin, and A. J. Feeney. 2008. Repertoire-based selection into the marginal zone compartment during B cell development. J. Exp. Med. 205: 2043-2052.
116. Dammers, P. M., A. Visser, E. R. Popa, P. Nieuwenhuis, and F. G. Kroese. 2000. Most marginal zone B cells in rat express germline encoded Ig VH genes and are ligand selected. J. Immunol. 165: 6156-6169.
117. Schelonka, R. L., J. Tanner, Y. Zhuang, G. L. Gartland, M. Zemlin, and H. W. Schroeder, Jr. 2007. Categorical selection of the antibody repertoire in splenic B cells. Eur. J. Immunol. 37: 1010-1021.
118. Allman, D., and S. Pillai. 2008. Peripheral B cell subsets. Curr. Opin. Immunol. 20: 149-157.
119. Song, H., and J. Cerny. 2003. Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J. Exp. Med. 198: 1923-1935.
120. Phan, T. G., S. Gardam, A. Basten, and R. Brink. 2005. Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J. Immunol. 174: 4567-4578. (Pubitemid 40504536)